Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Mice - Mice, Inbred BALB C

Terms

157Mice
73Mice, Inbred BALB C
406Animals
372Humans
91Influenza, Human (virology)
89Influenza, Human (epidemiology)
50Orthomyxoviridae Infections (immunology)
192Influenza A virus (immunology)

Associations

Freq.WeightAssociation
670.626Mice - Mice, Inbred BALB C
1560.618Animals - Mice
1860.479Animals - Humans
910.495Humans - Influenza, Human (virology)
890.489Humans - Influenza, Human (epidemiology)
400.451Mice - Orthomyxoviridae Infections (immunology)
1250.448Animals - Influenza A virus (immunology)
390.433Influenza, Human (epidemiology) - Influenza, Human (virology)
730.424Animals - Mice, Inbred BALB C
1050.393Humans - Influenza A virus (immunology)
220.364Mice, Inbred BALB C - Orthomyxoviridae Infections (immunology)
610.351Influenza A virus (immunology) - Mice
500.351Animals - Orthomyxoviridae Infections (immunology)
560.291Animals - Influenza, Human (virology)
310.262Influenza A virus (immunology) - Mice, Inbred BALB C
520.215Humans - Mice
200.204Influenza A virus (immunology) - Orthomyxoviridae Infections (immunology)
360.189Animals - Influenza, Human (epidemiology)
180.151Influenza, Human (virology) - Mice
200.121Humans - Mice, Inbred BALB C
150.110Humans - Orthomyxoviridae Infections (immunology)
140.107Influenza A virus (immunology) - Influenza, Human (epidemiology)
110.083Influenza A virus (immunology) - Influenza, Human (virology)

Documents par ordre de pertinence
000513 (2015) Daniel Dlugolenski [États-Unis] ; Les Jones [États-Unis] ; Elizabeth Howerth [États-Unis] ; David Wentworth [États-Unis] ; S. Mark Tompkins [États-Unis] ; Ralph A. Tripp [États-Unis]Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression
000C34 (2011) Yanwei Zhong [République populaire de Chine] ; Jiong Cai [République populaire de Chine] ; Chuanfu Zhang [République populaire de Chine] ; Xiaoyan Xing [République populaire de Chine] ; Enqiang Qin [République populaire de Chine] ; Jing He [République populaire de Chine] ; Panyong Mao [République populaire de Chine] ; Jun Cheng [République populaire de Chine] ; Kun Liu [République populaire de Chine] ; Dongping Xu [République populaire de Chine] ; Hongbin Song [République populaire de Chine]Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A
001220 (2008) Lisa M. Alleva [Australie] ; Alison C. Budd ; Ian A. ClarkSystemic release of high mobility group box 1 protein during severe murine influenza.
000212 (2018) Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie]Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
000283 (2017) Mizuho Suzuki ; Masatoshi Okamatsu ; Takahiro Hiono ; Keita Matsuno ; Yoshihiro SakodaPotency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice
000465 (2016) Sergio M. Qui Ones-Parra [Australie] ; E. Bridie Clemens [Australie] ; Zhongfang Wang [Australie] ; Hayley A. Croom [Australie] ; Lukasz Kedzierski [Australie] ; Jodie Mcvernon [Australie] ; Dhanasekaran Vijaykrishna [Singapour] ; Katherine Kedzierska [Australie]A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses
000533 (2015) Larisa Rudenko [Russie] ; Irina Isakova-SivakPandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
000556 (2015) Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine]Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge.
000697 (2014) Irina V. Alymova [États-Unis] ; Ian A. York [États-Unis] ; Jonathan A. Mccullers [États-Unis]Non-Avian Animal Reservoirs Present a Source of Influenza A PB1-F2 Proteins with Novel Virulence-Enhancing Markers
000750 (2014) Arkadiusz Wyrzucki [Suisse] ; Cyrille Dreyfus [États-Unis] ; Ines Kohler [Suisse] ; Marco Steck [Suisse] ; Ian A. Wilson [États-Unis] ; Lars Hangartner [Suisse]Alternative Recognition of the Conserved Stem Epitope in Influenza A Virus Hemagglutinin by a VH3-30-Encoded Heterosubtypic Antibody
000825 (2013) Cyrille Dreyfus ; Damian C. Ekiert ; Ian A. WilsonStructure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
000A23 (2012) Jianzhong Shi [République populaire de Chine] ; Zhiyuan Wen ; Jing Guo ; Ying Zhang ; Guohua Deng ; Yuelong Shu ; Dayan Wang ; Yongping Jiang ; Yoshihiro Kawaoka [États-Unis] ; Zhigao Bu ; Hualan ChenProtective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
000A76 (2012) Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. RudenkoComparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
000B46 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000B47 (2012) Ashok K. Chockalingam [États-Unis] ; Danielle Hickman [États-Unis] ; Lindomar Pena [États-Unis] ; JIANQIANG YE [États-Unis] ; Andrea Ferrero [États-Unis] ; Jose R. Echenique [Argentine] ; HONGJUN CHEN [États-Unis] ; Troy Sutton [États-Unis] ; Daniel R. Perez [États-Unis]Deletions in the Neuraminidase Stalk Region of H2N2 and H9N2 Avian Influenza Virus Subtypes Do Not Affect Postinfluenza Secondary Bacterial Pneumonia
000E67 (2010) Chih-Jen Wei [États-Unis] ; Jeffrey C. Boyington ; Patrick M. Mctamney ; Wing-Pui Kong ; Melissa B. Pearce ; Ling Xu ; Hanne Andersen ; Srinivas Rao ; Terrence M. Tumpey ; Zhi-Yong Yang ; Gary J. NabelInduction of broadly neutralizing H1N1 influenza antibodies by vaccination.
000F05 (2010) Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis]Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿
000F07 (2010) Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
001121 (2009) Reiko Yoshida [Japon] ; Manabu Igarashi ; Hiroichi Ozaki ; Noriko Kishida ; Daisuke Tomabechi ; Hiroshi Kida ; Kimihito Ito ; Ayato TakadaCross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
001283 (2008) Tomy Joseph [États-Unis] ; Josephine Mcauliffe ; Bin Lu ; Leatrice Vogel ; David Swayne ; Hong Jin ; George Kemble ; Kanta SubbaraoA live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.
001569 (2006) J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis]Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential
001872 (2001) M. D. Wareing [Australie] ; J. M. Watson [Australie] ; M. J. Brooks [Australie] ; G. A. Tannock [Australie]Immunogenic and isotype‐specific responses to russian and US cold‐adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice
001901 (2000) D J Alexander [Royaume-Uni] ; I H BrownRecent zoonoses caused by influenza A viruses.
001A67 (1998) Suryaprakash Sambhara [Suède] ; Samantha Woods [Suède] ; Rita Arpino [Suède] ; Anjna Kurichh [Suède] ; Alan Tamane [Suède] ; Brian Underdown [Suède] ; Michel Klein [Suède] ; Karin Lövgren Bengtsson [Suède] ; Bror Morein [Suède] ; David Burt [Suède]Heterotypic Protection against Influenza by Immunostimulating Complexes Is Associated with the Induction of Cross-Reactive Cytotoxic T Lymphocytes
001C00 (1996) H. Sagawa [Japon] ; A. Ohshima ; I. Kato ; Y. Okuno ; Y. IsegawaThe immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region.
001E47 (1994) M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis]Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses
002199 (1988) A. Müllbacher ; G L Ada ; R T HlaGamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses.
002343 (1986) H H Walls ; M W Harmon ; J J Slagle ; C. Stocksdale ; A P KendalCharacterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses.
002754 (1981) H. Ertl [Australie] ; G. L. Ada [Australie]Roles of influenza virus infectivity and glycosylation of viral antigen for recognition of target cells by cytolytic T Lymphocytes
002D76 (????) F G Nagieva ; N I Krasnova ; V G Nikulina ; O G Andzhaparidze[The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
002D88 (????) Iu A. Desheva ; T A Smolonogina ; M V Sergeeva ; A R Rekstin ; D. Swayne ; A I Klimov ; L G Rudenko[Study of biological properties of cold-adapted reassortant strain of influenza virus subtype H7N3].
002E09 (????) Christoph Scholtissek [États-Unis][Influenza pandemic planning].
002E11 (????) L A Stepanova ; A A Kovaleva ; M V Potapchuk ; A V Korotkov ; V V Kupriianov ; E A Blokhina ; R Iu Kotliarov ; L M Tsybalova[Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
000166 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000286 (2017) Zhu-Nan Li [États-Unis] ; Jessica F. Trost [États-Unis] ; Kimberly M. Weber [États-Unis] ; Elizabeth H. Lemasters [États-Unis] ; Sharifa Nasreen [Bangladesh] ; Javan Esfandiari [États-Unis] ; Angelo H. Gunasekera [États-Unis] ; Megan Mccausland [États-Unis] ; Katharine Sturm-Ramirez [États-Unis] ; Jens Wrammert [États-Unis] ; Sean Gregory [États-Unis] ; Vic Veguilla [États-Unis] ; James Stevens [États-Unis] ; Joseph D. Miller [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Min Z. Levine [États-Unis]Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.
000318 (2017) Brian J. Lenny [États-Unis] ; Stephanie Sonnberg [États-Unis] ; Angela F. Danner [États-Unis] ; Kimberly Friedman [États-Unis] ; Richard J. Webby [États-Unis] ; Robert G. Webster [États-Unis] ; Jeremy C. Jones [États-Unis]Evaluation of Multivalent H2 Influenza Pandemic Vaccines in Mice
000355 (2017) Troy C. Sutton [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Kevin W. Bock [États-Unis] ; Ian N. Moore [États-Unis] ; Wouter Koudstaal [Pays-Bas] ; Muniza Rehman [Pays-Bas] ; Gerrit Jan Weverling [Pays-Bas] ; Jaap Goudsmit [Pays-Bas] ; Kanta Subbarao [États-Unis]In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
000412 (2016) Alex W. H. Chin ; Hui-L. Yen ; Scott Krauss ; Richard J. Webby ; Leo L. M. PoonRecombinant influenza virus with a pandemic H2N2 polymerase complex has a higher adaptive potential than one with seasonal H2N2 polymerase complex
000420 (2016) Nachiket Shembekar [Inde] ; Vamsee V Aditya Mallajosyula [Inde] ; Ankita Malik [Inde] ; Ashok Saini [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Neutralization and Binding Profile of Monoclonal Antibodies Generated Against Influenza A H1N1 Viruses.
000498 (2015) A V Lyapunov ; S I Kolesnikov ; M A Khasnatinov ; E L Manzarova ; I V Petrova ; V V Dolgikh ; G A Danchinova[Child and Adolescent Interepydemic Immunity to Influenza Viruses].
000509 (2015) Isabel Wendel [Allemagne] ; Dennis Rubbenstroth [Allemagne] ; Jennifer Doedt [Allemagne] ; Georg Kochs [Allemagne] ; Jochen Wilhelm [Allemagne] ; Peter Staeheli [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne]The Avian-Origin PB1 Gene Segment Facilitated Replication and Transmissibility of the H3N2/1968 Pandemic Influenza Virus
000529 (2015) Zhong-Wei Zhang [République populaire de Chine] ; Ting Liu [République populaire de Chine] ; Jian Zeng [République populaire de Chine] ; Yang-Er Chen [République populaire de Chine, Suède] ; Ming Yuan [République populaire de Chine, États-Unis] ; Da-Wei Zhang [République populaire de Chine, États-Unis] ; Feng Zhu [République populaire de Chine] ; Shu Yuan [République populaire de Chine]Prediction of the next highly pathogenic avian influenza pandemic that can cause illness in humans
000565 (2015) Ankita Malik [Inde] ; V Vamsee Aditya Mallajosyula [Inde] ; Nripendra Nath Mishra [Inde] ; Raghavan Varadarajan [Inde] ; Satish Kumar Gupta [Inde]Generation and Characterization of Monoclonal Antibodies Specific to Avian Influenza H5N1 Hemagglutinin Protein.
000670 (2014) Jeremy C. Jones ; Tatiana Baranovich ; Bindumadhav M. Marathe ; Angela F. Danner ; Jon P. Seiler ; John Franks ; Elena A. Govorkova ; Scott Krauss ; Robert G. WebsterRisk Assessment of H2N2 Influenza Viruses from the Avian Reservoir
000730 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
000754 (2014) Udayan Joseph [Singapour] ; Martin Linster [Singapour, Pays-Bas] ; Yuka Suzuki [Singapour] ; Scott Krauss [États-Unis] ; Rebecca A. Halpin [États-Unis] ; Dhanasekaran Vijaykrishna [Singapour] ; Thomas P. Fabrizio [États-Unis] ; Theo M. Bestebroer [Pays-Bas] ; Sebastian Maurer-Stroh [Singapour] ; Richard J. Webby [États-Unis] ; David E. Wentworth [États-Unis] ; Ron A. M. Fouchier [Pays-Bas] ; Justin Bahl [Singapour, États-Unis] ; Gavin J. D. Smith [Singapour, États-Unis]Adaptation of Pandemic H2N2 Influenza A Viruses in Humans
000833 (2013) Alexandru Coman [Roumanie] ; Daniel N. Maftei ; Whitney S. Krueger ; Gary L. Heil ; John A. Friary ; Razvan M. Chereches ; Emanuela Sirlincan ; Paul Bria ; Claudiu Dragnea ; Iosif Kasler ; Gregory C. GraySerological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers.
000864 (2013) Wen He [République populaire de Chine] ; Wei Wang ; Huamin Han ; Lei Wang ; Ge Zhang ; Bin GaoMolecular basis of live-attenuated influenza virus.
000A21 (2012) Juergen A. Richt [États-Unis] ; Barry Rockx [Canada] ; Wenjun Ma [États-Unis] ; Friederike Feldmann [Canada] ; David Safronetz [Canada] ; Andrea Marzi [Canada] ; Darwyn Kobasa [Canada] ; James E. Strong [Canada] ; Lisa Kercher [États-Unis] ; Dan Long [États-Unis] ; Don Gardner [États-Unis] ; Douglas Brining [États-Unis] ; Heinz Feldmann [Canada]Recently Emerged Swine Influenza A Virus (H2N3) Causes Severe Pneumonia in Cynomolgus Macaques
000A72 (2012) Gunisha Pasricha ; Akhilesh C. Mishra ; Alok K. ChakrabartiComprehensive global amino acid sequence analysis of PB1F2 protein of influenza A H5N1 viruses and the influenza A virus subtypes responsible for the 20th‐century pandemics
000C28 (2011) Darisuren Anhlan [Allemagne] ; Norbert Grundmann ; Wojciech Makalowski ; Stephan Ludwig ; Christoph ScholtissekOrigin of the 1918 pandemic H1N1 influenza A virus as studied by codon usage patterns and phylogenetic analysis.
000D08 (2011) Gary J. Nabel [États-Unis] ; Chih-Jen Wei [États-Unis] ; Julie E. Ledgerwood [États-Unis]Vaccinate for the next H2N2 pandemic now
000D56 (2011) Hans-Dieter Klenk [Allemagne]Influenzaviren auf dem Weg vom Tier zum Menschen. Grippeausbrüche
000E09 (2010) Katy M. Graef ; Frank T. Vreede ; Yuk-Fai Lau ; Amber W. Mccall ; Simon M. Carr ; Kanta Subbarao ; Ervin FodorThe PB2 Subunit of the Influenza Virus RNA Polymerase Affects Virulence by Interacting with the Mitochondrial Antiviral Signaling Protein and Inhibiting Expression of Beta Interferon▿
000E31 (2010) Claudia Pappas [États-Unis] ; Karthik Viswanathan [États-Unis] ; Aarthi Chandrasekaran [États-Unis] ; Rahul Raman [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Ram Sasisekharan [États-Unis] ; Terrence M. Tumpey [États-Unis]Receptor Specificity and Transmission of H2N2 Subtype Viruses Isolated from the Pandemic of 1957
000E40 (2010) Ryan A. Langlois [États-Unis] ; Kevin L. LeggePlasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
000F06 (2010) C. Yea [Canada] ; M. Petric ; J. Pasick ; R. TellierA new RT-PCR assay specific for influenza A(H2), multiplexed with an assay specific for HPAI A(H5N1).
000F44 (2010) J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas]Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model
000F91 (2010) Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis]Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets
001018 (2009) Ning Du ; Xiao-Xing Yang ; Lei Yang ; Yu-Hong Zeng ; Shu-Mei Zou ; Hong Bo ; Yuan-Ji Guo ; De-Xin Li ; Yue-Long Shu[Review on the etiological property of 1957 Asian flu virus (H2N2)].
001023 (2009) Jeff Alexander [États-Unis] ; Pamuk Bilsel [États-Unis] ; Marie-France Del Guercio [États-Unis] ; Stephani Stewart [États-Unis] ; Aleksandra Marinkovic-Petrovic [États-Unis] ; Scott Southwood [États-Unis] ; Claire Crimi [États-Unis] ; Lo Vang [États-Unis] ; Les Walker [États-Unis] ; Glenn Ishioka [États-Unis] ; Vivek Chitnis [États-Unis] ; Alessandro Sette [États-Unis] ; Erika Assarsson [États-Unis] ; Drew Hannaman [États-Unis] ; Jason Botten [États-Unis] ; Mark J. Newman [États-Unis]Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice
001041 (2009) Rui Xu ; Ryan Mcbride ; James C. Paulson ; Christopher F. Basler ; Ian A. WilsonStructure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic▿ †
001062 (2009) Ilaria Capua [Italie] ; Anna Kajaste-Rudnitski [Italie] ; Elena Bertoli [Italie] ; Elisa Vicenzi [Italie]Pandemic Vaccine Preparedness—Have We Left Something Behind?
001097 (2009) Carlos Franco-Paredes [États-Unis] ; Isabel Hernandez-Ramos ; Carlos Del Rio ; Kelly T. Alexander ; Roberto Tapia-Conyer ; Jose I. Santos-PreciadoH1N1 influenza pandemics: comparing the events of 2009 in Mexico with those of 1976 and 1918-1919.
001179 (2009) Jennifer Uhlendorff [Allemagne] ; Tatyana Matrosovich [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne]Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses
001230 (2008) Jodi Mcgill [États-Unis] ; Nico Van Rooijen ; Kevin L. LeggeProtective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs.
001260 (2008) Xueli Hao [États-Unis] ; Taeg S. Kim ; Thomas J. BracialeDifferential response of respiratory dendritic cell subsets to influenza virus infection.
001360 (2007) Heesik Yoon [États-Unis] ; Kevin L. Legge ; Sun-Sang J. Sung ; Thomas J. BracialeSequential activation of CD8+ T cells in the draining lymph nodes in response to pulmonary virus infection.
001368 (2007) Sumanth Rajagopal [États-Unis] ; John TreanorPandemic (avian) influenza.
001383 (2007) Noelle K. Polakos [États-Unis] ; Ingo Klein ; Martin V. Richter ; Dietmar M. Zaiss ; Matthew Giannandrea ; Ian N. Crispe ; David J. TophamEarly intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses.
001452 (2007) Alison Budd [Australie] ; Lisa Alleva [Australie] ; Mohammed Alsharifi [Australie] ; Aulikki Koskinen [Australie] ; Victoria Smythe [Australie] ; Arno Müllbacher [Australie] ; Jeff Wood [Australie] ; Ian Clark [Australie]Increased survival after gemfibrozil treatment of severe mouse influenza
001482 (2006) Edwin D. Kilbourne [États-Unis]Influenza Pandemics of the 20th Century
001496 (2006) Kwang-Hee Lee [Corée du Sud] ; Sang-Uk Seo ; Jae-Min Song ; Chung-Min Lee ; Hyun-Ah Kim ; Baik L. SeongCharacterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
001571 (2006) Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong]Avian influenza virus infections in humans
001578 (2005) Mark D. Wareing [Australie] ; Leonard C. Harrison ; Gregory A. TannockPulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains.
001646 (2005) Takashi Suzuki [Japon] ; Tadanobu Takahashi [Japon] ; Chao-Tan Guo [Japon, République populaire de Chine] ; Kazuya I.-P. Jwa Hidari [Japon] ; Daisei Miyamoto [Japon] ; Hideo Goto [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] ; Yasuo Suzuki [Japon]Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication
001737 (2003) H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis]Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate
001807 (2001) Emi Tsuchiya ; Kanetsu Sugawara ; Seiji Hongo ; Yoko Matsuzaki ; Yasushi Muraki ; Zhu-Nan Li ; Kiyoto NakamuraAntigenic structure of the haemagglutinin of human influenza A/H2N2 virus.
001903 (2000) H. Masaki [Japon] ; M. Tamura ; I. KuraneInduction of cytotoxic T lymphocytes of heterogeneous specificities by immunization with a single peptide derived from influenza A virus.
001A43 (1998) J. Jameson [États-Unis] ; J. Cruz ; F A EnnisHuman cytotoxic T-lymphocyte repertoire to influenza A viruses.
001B99 (1996) W. Cao [États-Unis] ; B A Myers-Powell ; T J BracialeThe weak CD8+ CTL response to an influenza hemagglutinin epitope reflects limited T cell availability.
001D68 (1995) S. Chatterjee [Inde] ; K. K. Mukherjee [Inde] ; M. C. Mondal [Inde] ; S. K. Chakravarti [Inde] ; M. S. Chakraborty [Inde]A serological survey of influenza a antibody in human and pig sera in Calcutta
001D76 (1994) W. Cao ; B A Myers-Powell ; T J BracialeRecognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.
001E14 (1994) Yan Wu [États-Unis] ; Yang Liu [États-Unis]Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responses
001E35 (1994) Innocent N. Mbawuike [États-Unis] ; Susan B. Dillon [États-Unis] ; Sandra G. Demuth [États-Unis] ; Christopher S. Jones [États-Unis] ; Thomas R. Cate [États-Unis] ; Robert B. Couch [États-Unis]Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein
001F05 (1993) Judith R. Sch Ffr [Allemagne] ; Yoshihiro Kawaoka [Allemagne] ; William J. Bean [Allemagne] ; Jochen Süss [Allemagne] ; Dennis Senne [Allemagne] ; Robert G. Webster [Allemagne]Origin of the Pandemic 1957 H2 Influenza A Virus and the Persistence of Its Possible Progenitors in the Avian Reservoir
001F27 (1992) S Q Li [États-Unis] ; J L Schulman ; T. Moran ; C. Bona ; P. PaleseInfluenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes.
001F33 (1992) E. Kanta Subbarao [États-Unis] ; Mark Perkins [États-Unis] ; John J. Treanor [États-Unis] ; Brian R. Murphy [États-Unis]The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect
002128 (1990) I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. CouchVaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes
002129 (1990) G. N. Milligan [États-Unis] ; L. A. Morrison [États-Unis] ; J. Gorka ; V. L. Braciale [États-Unis] ; T. J. Braciale [États-Unis]The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen
002246 (1988) Maria Wysocka [États-Unis] ; Jack R. Bennink [États-Unis]Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products
002485 (1984) N K Mak ; C. Sweet ; G L Ada ; G A TannockThe sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses.
002490 (1984) J. Wilczy Ski ; S. Kru ; R. Semkow ; M. Loza-TulimowskaMetaplasia of the lung respiratory epithelium and antibody dynamics in mice repeatedly infected with various subtypes of influenza virus A.
002641 (1982) B L Lu ; R G Webster ; V S HinshawFailure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.
002708 (1981) M E Andrew ; T J BracialeAntigen-dependent proliferation of cloned continuous lines of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.
002971 (1978) W. J. J. Anker ; A. K. Bakker ; N. MasurelCross-Protection in Mice After Immunization with H2N2, H3N2, and Heq2Neq2 Influenza Virus Strains
002992 (1978) G. M. Butchko [États-Unis] ; R. B. Armstrong [États-Unis] ; W. J. Martin [États-Unis] ; F. A. Ennis [États-Unis]Influenza A viruses of the H2N2 subtype are lymphocyte mitogens
002A40 (1977) G E Rukavishnikova ; A K AlekseevaInfluenza virus antigens in human leukocytes after oral administration of live tissue culture influenza A monovaccine.
002A70 (1977) Colin Mclaren [États-Unis] ; Martha W. Verbonitz [États-Unis] ; Sylvester Daniel [États-Unis] ; George E. Grubbs [États-Unis] ; Francis A. Ennis [États-Unis]Effect of Priming Infection on Serologic Response to Whole and Subunit Influenza Virus Vaccines in Animals
002D95 (????) A R Rekstin ; K. Lu ; D. Kats ; L G Rudenko[Production of early cytokines after infection with A/Leningrad/134/57 (H2N2) wide-type virus and cold-adapted attenuated vaccine viruses].

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021